COMBINATION TREATMENT FOR CANCER

Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound...

Full description

Saved in:
Bibliographic Details
Main Authors OPALINSKA, JOANNA, MAYES, PATRICK, KHANDEKAR, SANJAY
Format Patent
LanguageEnglish
French
Published 21.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone). L'invention concerne une méthode de traitement du cancer, tel que le myélome multiple, impliquant la combinaison d'une protéine de liaison à l'antigène anti-BCMA (par exemple un anticorps anti-BCMA) et d'un médicament immunomodulateur (par exemple le pomalidomide ou le lénalidomide). Ces combinaisons peuvent également comprendre un composé anti-inflammatoire (par exemple la dexaméthasone).
AbstractList Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone). L'invention concerne une méthode de traitement du cancer, tel que le myélome multiple, impliquant la combinaison d'une protéine de liaison à l'antigène anti-BCMA (par exemple un anticorps anti-BCMA) et d'un médicament immunomodulateur (par exemple le pomalidomide ou le lénalidomide). Ces combinaisons peuvent également comprendre un composé anti-inflammatoire (par exemple la dexaméthasone).
Author MAYES, PATRICK
KHANDEKAR, SANJAY
OPALINSKA, JOANNA
Author_xml – fullname: OPALINSKA, JOANNA
– fullname: MAYES, PATRICK
– fullname: KHANDEKAR, SANJAY
BookMark eNrjYmDJy89L5WRQcPb3dfL0cwzx9PdTCAlydQzxdfULUXDzD1JwdvRzdg3iYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GBuam5oZmjobGRCgBAIqAIx8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate POLYTHERAPIE POUR LE TRAITEMENT DU CANCER
ExternalDocumentID CA3075716A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA3075716A13
IEDL.DBID EVB
IngestDate Fri Sep 06 06:12:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA3075716A13
Notes Application Number: CA20183075716
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190321&DB=EPODOC&CC=CA&NR=3075716A1
ParticipantIDs epo_espacenet_CA3075716A1
PublicationCentury 2000
PublicationDate 20190321
PublicationDateYYYYMMDD 2019-03-21
PublicationDate_xml – month: 03
  year: 2019
  text: 20190321
  day: 21
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
RelatedCompanies_xml – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Score 3.1864483
Snippet Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMBINATION TREATMENT FOR CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190321&DB=EPODOC&locale=&CC=CA&NR=3075716A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUkzBx0LngZMvOZJuiZJQCIJdBBkmnFiiqGBcZJxKnii3dfPzCPUxCvCNIKJIRO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwNrN2MhQzcXJ1jXA38XfWc3Z2dbZUc0vyBaYlE2BXQNHYEeJFdSKBh2z7xrmBNqUUoBco7gJMrAFAA3LKxFiYErNE2bgdIZdvCbMwOELne8GMqFZr1iEQcHZ39fJE3J4rUJIkKtjCOgYfgVgJ07BGXTBTJAog4Kba4izhy7Qqni4t-KdHeGOMhZjYAH29lMlGBQMUi0NTFKSDYH5DNiZMLZIMjRISzUwTzZJTjQCtQUkGSRxGiOFR06agQsUPqDlU0aGMgwsJUWlqbLA-rQkSQ4cEgCT3HTK
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUkzBx0LngZMvOZJuiZJQCIJdBBkmnFiiqGBcZJxKnii3dfPzCPUxCvCNIKJIRO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwNrN2MhQzcXJ1jXA38XfWc3Z2dbZUc0vyBaYlE2BXQNHYEeJ1Rx0OC-o5RTmBNqUUoBco7gJMrAFAA3LKxFiYErNE2bgdIZdvCbMwOELne8GMqFZr1iEQcHZ39fJE3J4rUJIkKtjCOgYfgVgJ07BGXTBTJAog4Kba4izhy7Qqni4t-KdHeGOMhZjYAH29lMlGBQMUi0NTFKSDYH5DNiZMLZIMjRISzUwTzZJTjQCtQUkGSRxGiOFR06egdMjxNcn3sfTz1uagQsUVqClVEaGMgwsJUWlqbLAurUkSQ4cKgAxyXe3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATION+TREATMENT+FOR+CANCER&rft.inventor=OPALINSKA%2C+JOANNA&rft.inventor=MAYES%2C+PATRICK&rft.inventor=KHANDEKAR%2C+SANJAY&rft.date=2019-03-21&rft.externalDBID=A1&rft.externalDocID=CA3075716A1